New from @mdryser@DukeU and @fredhutch: previous estimates of #breastcancer overdiagnosis may have been overestimated—a new model suggests that overdiagnosis occurs in about 15% of screen-detected cancers. Video: https://t.co/d3VMjIQ80R #DCIS
@susan_bewley@pash22@angRchen@MichaelBaum11 @1987Andrewk May I kindly ask you to read the paper before you engage in disinformation. Our work is based on individual-level data from over 36,000 women from the high-quality Breast Cancer Surveillance Consortium. Read up about the data source here: https://t.co/NbzqKBTY6e
Ryser Laboratory (@mdryser) @DukeCancer@duke_pophealth has an opening for a Postdoctoral Associate to conduct longitudinal data analysis and cancer screening and surveillance modeling. To learn more, visit https://t.co/a55nHK2VhI #MDMTwitter
@DukeRec Came by at 2.30pm on May 28 and found Central Campus pool to be closed. Please tweet about early closures to spare people the trip over, thanks very much!
@schaumberg_a@EricTopol@PNASNews@DukeHealth@USC Thanks! The growth models were fit to each tumor individually, and the signal was consistent throughout. But validation against more tumors will be necessary in the future.
Are certain #cancers "born to be bad"?
A provocative study of propensity for early metastasis https://t.co/3rhJQZmL7Y @PNASNews by @mdryser et al @DukeHealth@USC
Join the DCIS conversation @ #SABCS17! Meet patient advocates for both COMET & PRECISION studies @ posters: Fri. 5-7PM. Also at posters Fri. morning meet PRECISION research team: Fri. 7-9AM When cancer may not really be cancer. #DCIS#BCSM https://t.co/FoWbo7Ns3G
Shelley Hwang of @DukeSurgery talking about primary endocrine therapy for ER+ DCIS in plenary session at #SABCS17, representing @DukeCancer and 23 other trial sites of CALGB 40903 (Alliance).